Skip to content

Filter by:

Keyword

Showing

CAR-T Cells in Solid Tumors: Overcoming Resistance Mechanisms for Effective Therapy

15.09.2025

In a recent article published in “Der Internist” (German), LIT scientists Dr. Markus Barden, Dr. Astrid Holzinger, and Prof. Hinrich Abken comprehensively review the challenges and emerging solutions for chimeric antigen receptor (CAR) T cell therapy in solid tumors. This overview is especially important for oncologists, immunologists, and medical researchers interested in cellular therapies against cancer.


LIT Scientist Awarded Highly Competitive Grant

11.09.2025

Gabriele Inchingolo, Ph.D. student in Prof. Luca Gattinoni’s lab at the Leibniz Institute for Immunotherapy, has been selected as one of the winners of Bruker’s inaugural Beacon Discovery Global Grant Program.



LIT Retreat 2025

09.09.2025

The LIT Retreat took place on July 28 and 29, 2025 at Haus Bayerischer Wald in Lam.


LIT PhD Student Awarded Prestigious Scholarship

14.08.2025

Julia Englbrecht, a doctoral student at the Research Group “Epigenetic Immuno-oncology”, headed by Dr. Christian Schmidl, has been awarded the highly competitive doctoral scholarship by the “Studienstiftung des deutschen Volkes”.


LIT Scientists Participate at RIGeL Summer School 2025

12.08.2025

PhD students from the Leibniz Institute for Immunotherapy (LIT) took part in the Summer School organized by the Regensburg International Graduate School of Life Sciences (RIGeL). Meghma Mukherjee has received the Best Poster Award, while Fabian Hölzl has been awarded the Best Questioner Prize. Dr. Christian Schmidl contributed as a guest lecturer at the event.



Development process of human tissue-healing immune cells deciphered

21.07.2025

Researchers at the Leibniz Institute for Immunotherapy (LIT), together with the University Medical Center Mainz and the German Cancer Research Center, are investigating how certain immune cells—so-called Treg cells—develop into Treg cells with special healing abilities in the human immune system. To do this, they analyze the genetic fingerprint of these cells. Their findings are bringing them closer to being able to use these specialized cells for therapeutic purposes in the future.



Prof. Gattinoni Highlights Breakthrough on Cancer’s Mitochondrial Boost in Science Magazine

10.07.2025

A groundbreaking study reported in Nature and discussed in Science Magazine has revealed that neurons donate mitochondria, the cell’s powerhouse, to cancer cells, dramatically boosting tumor growth and spread. By transferring these energy-producing organelles, nerve cells effectively “supercharge” cancer cells, helping them survive, multiply, and metastasize to other parts of the body.